September 8, 2016
Premaitha Health welcomes new board member
David Evans, Non-executive Chairman, has stepped down from the Board with immediate effect.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
September 6, 2016
Quay Pharma to formulate capsules to be be administered in Redx’s trial
Quay Pharma will be formulating the capsules that will be administered in Redx’s trial.
September 6, 2016
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
August 25, 2016
Positive Phase III EXPAND study for Novartis
Positive Phase III EXPAND study for Novartis
July 29, 2016
Sanofi reports net income €1,158m, down 11.1%
“Second quarter financial performance was in-line with expectations.” – Olivier Brandicourt, Sanofi CEO
July 25, 2016
Faron and Abzena in cancer medicine Clevegen manufacture deal
Faron and Abzena in cancer medicine Clevegen manufacture deal
July 8, 2016
Vernalis completes its CCP-08 pivotal bioavailability studies
Vernalis has today announced the completion of the CCP-08 pivotal multiple-dose comparative bioavailability study.
July 8, 2016
Allergy Therapeutics Acarovac Plus one year study published
Allergy Therapeutics Acarovac Plus one year study published
July 8, 2016
PureTech Health introduces new members to its Scientific Advisory Board
PureTech Health has introduced new members to its Scientific Advisory Board
July 4, 2016
English Court to consider Premaitha’s defence on Illumia filed case after hearing scheduled for July 2017
English Court to consider Premaitha’s defence after hearing scheduled for July 2017